ArticleActas espanolas de psiquiatria2025
Description of Motor Stereotypies in Adolescents and Adults With Autistic Spectrum Disorder.
Article in Actas espanolas de psiquiatria, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interplay between motor stereotypies, emotional dysregulation, and sensory reactivity in adolescents and adults with autism spectrum disorder.European archives of psychiatry and clinical neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMotor stereotypies (MS) are highly prevalent in children with autism spectrum disorders (ASD) and, although they tend to decrease with age, may persist into adulthood. The primary objective of this study was to describe the frequency, severity, number, and types of MS in adolescents and adults with ASD, to retrospectively evaluate their evolution over time, as well as to examine their relationship with sociodemographic and clinical variables.
methodsA sample of 90 adolescents and adults with ASD were included in a cross-sectional and retrospective study. Rojahn's Stereotypic Behavior Scale (SBS) was used to measure the frequency, severity, and types of MS, while the Achenbach System of Empirically Based Assessment (ASEBA) inventories were utilized to assess psychiatric comorbidity.
resultsMS were observed in 86.5% of cases. The most frequent MS in adolescents and adults with ASD were complex hand and finger movements and pacing (both of which were the most persistent over time) and repetitive body movements (which decreased in periodicity over time). Other, more socially inappropriate MS diminished over time. A significant reduction in the frequency and severity of MS was observed. No correlation was found between age and frequency of MS, and no differences were observed between men and women. Individuals with ASD and intellectual disability (ID) exhibited more types of MS per case and more frequent MS than those without ID, although these differences were not statistically significant. The ASD group with psychopathological comorbidities showed greater frequency and severity of MS, as well as more types of MS per case.
conclusionsMS decreased in frequency and severity over time but persisted in ASD, particularly those that are more specific to ASD. The most socially inappropriate MS tended to disappear. The presence of MS in adolescents and adults with ASD was not influenced by age or sex. Adolescents and adults with ASD and ID or psychopathological comorbidities exhibited a greater variety of stereotypies, with the psychopathological comorbidities group showing higher frequency and severity of MS. Understanding the characteristics of MS could aid in predicting their progression, designing more targeted treatments (if needed), and identifying phenotypic subgroups to facilitate the discovery of associated risk genes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.